RankingsPricing
  1. JP-listed companies
  2. EnBio Holdings,Inc
  3. Financials
  4. Revenue

EnBio Holdings,IncJP:6092

Market cap
¥4.8B
P/E ratio
6.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202510,668+11.41%
Mar 31, 20249,576+17.92%
Mar 31, 20238,120-9.65%
Mar 31, 20228,988+31.39%
Mar 31, 20216,841-7.67%
Mar 31, 20207,408-13.48%
Mar 31, 20198,563+2.09%
Mar 31, 20188,388+56.85%
Mar 31, 20175,348+95.73%
Mar 31, 20162,732+38.03%
Mar 31, 20151,979-6.12%
Mar 31, 20142,109+41.20%
Mar 31, 20131,493+6.92%
Mar 31, 20121,397

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)